Metagenomi, Inc. Common Stock
MGX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20,393 | -$19,908 | -$25,039 | -$23,398 |
| Dep. & Amort. | $1,324 | $1,335 | $1,358 | $1,461 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $2,928 | $3,412 |
| Change in WC | -$5,636 | -$7,935 | -$2,278 | -$15,456 |
| Other Non-Cash | $3,452 | $5,257 | $189 | $7,705 |
| Operating Cash Flow | -$21,253 | -$21,251 | -$22,842 | -$26,276 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$74 | -$127 | -$288 | -$334 |
| Net Acquisitions | $0 | $37 | $0 | $0 |
| Inv. Purchases | -$6,063 | -$18,509 | -$22,287 | -$12,341 |
| Inv. Sales/Matur. | $33,500 | $37,671 | $47,303 | $41,220 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $27,363 | $19,072 | $24,728 | $28,545 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $109 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$187 | -$275 | -$77 | $0 |
| Financing Cash Flow | -$187 | -$166 | -$77 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $5,923 | -$2,345 | $1,809 | $2,269 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $26,850 | $29,195 | $32,634 | $30,365 |
| End Cash | $32,773 | $26,850 | $34,443 | $32,634 |
| Free Cash Flow | -$21,327 | -$21,378 | -$23,130 | -$26,610 |